Hepatology References
REFERENCES IN CHRONOLOGICAL ORDER |
(Updated on June 3, 2010) |
2010
Valva P, De Matteo E, Galoppo MC, Gismondi MI , Preciado MV. (2010)
Apoptosis markers related to pathogenesis of pediatric chronic hepatitis C virus infection: M30 mirrors the severity of steatosis.
J Med Virol. 82(6):949-57.
»Abstract
Bechmann LP, Gieseler RK, Sowa JP, Kahraman A, Erhard J, Wedemeyer I, Emons B, Jochum C, Feldkamp T, Gerken G, Canbay A. (2010)
Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis.
Liver Int. 2010 Apr 9. [Epub ahead of print]
»Abstract
Tsutsui M, Tanaka N, Kawakubo M, Sheena Y, Horiuchi A, Komatsu M,, Nagaya T, Joshita S, Yoshizawa K, Aoyama T, Tanaka E, Sano K. (2010)
Serum Fragmented Cytokeratin 18 Levels Reflect the Histologic Activity Score of Nonalcoholic Fatty Liver Disease More Accurately Than Serum Alanine Aminotransferase Levels.
J Clin Gastroenter e-pub Jan 25
»Abstract
Papatheodoridis GV, Hadziyannis E, Tsochatzis E, Georgiou A, Kafiri G, Tiniakos DG, Margariti K, Archimandritis AJ. (2010)
Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic Fatty liver disease.
J Clin Gastroenter 44: 87-95.
»Abstract
Kahraman A, Schlattjan M, Kocabayoglu P, Yildiz-Meziletoglu S, Schlensak M, Fingas CD, Wedemeyer I, Marquitan G, Gieseler RK, Baba HA, Gerken G, Canbay A. (2010)
Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis.
Hepatology 51, 92-102.
»Abstract
Tan S, Bechmann LP, Benson S, Dietz T, Eichner S, Hahn S, Janssen OE, Lahner H, Gerken G, Mann K, Canbay A. (2010)
Apoptotic markers indicate nonalcoholic steatohepatitis in polycystic ovary syndrome.
J Clin Endocrinol Metab. 95:343-8.
»Abstract
Civera M, Urios A, Garcia-Torres ML, Ortega J, Martinez-Valls J, Cassinello N, Del Olmo JA, Ferrandez A, Rodrigo JM, Montoliu C. (2010)
Relationship between insulin resistance, inflammation and liver cell apoptosis in patients with severe obesity.
Diabetes Metab Res Rev. 2010 Mar 10.
»Abstract
Sgier C, Müllhaupt B, Gerlach T, Moradpour D, Negro F, Malé PJ, Heim MH, Malinverni R, Cerny A, Dufour JF. (2010)
Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C.
J Viral Hepat. 2010 Jan 13.
»Abstract
Balmer ML, Siegrist K, Zimmermann A, Dufour JF. (2009)
Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and apoptosis in patients with nonalcoholic steatohepatitis.
Liver Int. 2009 Apr 17
»Abstract
Bantel H, Schulze-Osthoff K. (2009)
Cell death in sepsis: a matter of how, when, and where.
Crit Care. 2009;13(4):173.
»Abstract
Feldstein A, Wieckowska A, Lopez AR, Liu YC, Zein NN, McCullough AJ. (2009)
Cytokeratin-18 fragment levels as noninvasive biomarker for nonalcoholic steatohepatitis: A multicenter validation study.
Hepatology, Volume: 9999 (in press)
»Abstract
To the editor:
Yilmaz Y (2009)
Defragmenting the noninvasive diagnosis of nonalcoholic steatohepatitis: Hopes from cytokeratin-18.
Hepatology, Published Online: 11 May 2009
»Abstract
To the editor:
Bantel H, Bahr MJ, Schulze-Osthoff K. (2009)
An apoptosis biomarker for prediction of nonalcoholic steatohepatitis.
Hepatology, Volume: 9999 (in press)
»Abstract
Feldstein A, Kleiner D, Kravetz D, Buck M. (2009)
Severe hepatocellular injury with apoptosis induced by a hepatitis C polymerase inhibitor.
J Clin Gastroenterol. 2009 Apr;43(4):374-81.
»Abstract
Hashimoto E, Farrell GC. (2009)
Will non-invasive markers replace liver biopsy for diagnosing and staging fibrosis in non-alcoholic steatohepatitis?
J Gastroenterol Hepatol. 2009 Apr;24(4):501-3.
»Abstract and article
Malik R, Chang M, Bhaskar K, Nasser I, Curry M, Schuppan D, Byrnes V, Afdhal N. (2009)
The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease.
J Gastroenterol Hepatol. 2009 Apr;24(4):564-8.
»Abstract
Musso G, Gambino R, Pacini G, Pagano G, Durazzo M, Cassader M. (2009)
Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH.
Hepatology. 2009 Feb;49(2):426-35.
»Abstract
Musso G, Gambino R, Pacini G, De Michieli F, Cassader M. (2009)
Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver.
Am J Clin Nutr. 2009 Feb;89(2):558-67. Epub 2009 Jan 13.
»Abstract
Hofer S, Brenner T, Bopp C, Steppan J, Lichtenstern C, Weitz J, Bruckner T, Martin E, Hoffmann U and Weigand. (2009)
Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction
Critical Care 2009, 13:R93.
»Abstract and article
Jochum C, Gieseler RK, Gawlista I, Fiedler A, Manka P, Saner FH, Roggendorf M, Gerken G, Canbay A. (2009)
Hepatitis B-associated Acute Liver Failure: Immediate Treatment with Entecavir Inhibits Hepatitis B Virus Replication and Potentially Its Sequelae
Digestion. 2009 Oct 15;80(4):235-240.
»Abstract
Yilmaz Y (2009)
Systematic review caspase-cleaved fragments of cytokeratin 18 – the promises and challenges of a biomarker for chronic liver disease
Aliment Pharmacol Ther. 2009 Dec 1;30(11-12):1103-9
»Abstract
Yilmaz Y, Kedrah AE, Ozdogan O. (2009)
Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis.
World J Gastroenterol. 2009 Sep 21;15(35):4387-91.
»Abstract
Wedemeyer I, Bechmann LP, Odenthal M, Jochum C, Marquitan G, Drebber U, Gerken G, Gieseler RK, Dienes HP, Canbay A. (2009)
Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C.
J Hepatol. 2009 Jan;50(1):140-9. Epub 2008 Nov 7.
»Abstract
2008
Bechmann LP., Marquitan G, Jochum C, Saner F, Gerken G, Canbay A. (2008)
Apoptosis versus necrosis rate as a predictor in acute liver failure following acetaminophen intoxication compared with acute‑on‑chronic liver failure
Liver International 2008 May;28(5):713‑6
»Abstract
Diab DL, Yerian L, Schauer P, Kashyap SR, Lopez R, Hazen SL, Feldstein AE. (2008)
Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients.
Clin Gastroenterol Hepatol. 2008 Nov;6(11):1249-54. Epub 2008 Jul 26.
»Abstract
Papatheodoridis GV, Hadizyannis E, Tsochatzis E, Chrysanthos N, Georgiou A, Kafiri G, Manolakopoulos S, Tiniakos DG, Giannousis I, Manesis E, Archimandritis AJ. (2008)
Serum Apoptotic Caspase Activity As A Marker Of Severity In Hbeag‑Negative Chronic Hepatitis B Virus Infection.
Gut. 2008 Apr;57(4):500‑6.
»Abstract
Simopoulos C, Tsaroucha AK, Asimakopoulos B, Giatromanolaki A, Gavriilidis P, Polychronidis A, Karayiannakis A. (2008)
Total and caspase‑cleaved cytokeratin 18 in chronic cholecystitis: A prospective study.
BMC Gastroenterol. 2008 May 6;8(1):14 [Epub ahead of print]
»Abstract
Volkmann X, Anstaett M, Hadem J, Stiefel P, Bahr MJ, Lehner F, Manns MP, Schulze‑Osthoff K, Bantel H. (2008)
Caspase activation is associated with spontaneous recovery from acute liver failure.
Hepatology. 2008 May;47(5):1624‑33.
»Abstract
Vos MB, Barve S, Joshi-Barve S, Carew JD, Whitington PF, McClain CJ. (2008)
Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease.
J Pediatr Gastroenterol Nutr. 2008 Oct;47(4):481-5
»Abstract
Wieckowska A, Feldstein AE. (2008)
Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive.
Semin Liver Dis. 2008 Nov;28(4):386-95. Epub 2008 Oct 27.
»Abstract
Younossi ZM, Jarrar M, Nugent C, Randhawa M, Afendy M, Stepanova M, Rafiq N, Goodman Z, Chandhoke V, Baranova A. (2008)
A Novel Diagnostic Biomarker Panel for Obesity‑related Nonalcoholic Steatohepatitis (NASH).
Obes Surg. 2008 Nov;18(11):1430-7. Epub 2008 May 24.
»Abstract
2007
Hetz H, Hoetzenecker K, Hacker S, Faybik P, Pollreisz A, Moser B, Roth G, Hoetzenecker W, Lichtenauer M, Klinger M, Krenn CG, Ankersmit HJ. (2007)
Caspase‑cleaved cytokeratin 18 and 20 S proteasome in liver degeneration.
J Clin Lab Anal. 2007;21(5):277‑81.
»Abstract
Mitry RR, De Bruyne R, Quaglia A, Hughes RD, Dhawan A. (2007)
Noninvasive diagnosis of nonalcoholic fatty liver disease using serum biomarkers.
Hepatology. 2007 Nov 28;46(6):2047‑2048 [Epub ahead of print]
»Abstract
Neuman MG, Benhamou JP, Marcellin P, Valla D, Malkiewicz IM, Katz GG, Trepo C, Bourliere M, Cameron RG, Cohen L, Morgan M, Schmilovitz‑Weiss H, Ben‑Ari Z. (2007)
Cytokine‑chemokine and apoptotic signatures in patients with hepatitis C.
Transl Res. 2007 Mar;149(3):126‑36.
»Abstract
Rutherford AE, Hynan LS, Borges CB, Forcione DG, Blackard JT, Lin W, Gorman AR, Shaikh OS, Reuben A, Harrison E, Reddy KR, Le WM, Chung RT; For the alf study group. (2007)
Serum Apoptosis Markers in Acute Liver Failure: A Pilot Study.
Clin Gastroenterol Hepatol. 2007 Oct 27; [Epub ahead of print]
»Abstract
Tumurbaatar B, Sun Y, Chan T, Sun J. (2007)
Cre‑estrogen receptor‑mediated hepatitis C virus structural protein expression in mice.
J Virol Methods. 2007 Dec;146(1‑2):5‑13. Epub 2007 Jul 12.
»Abstract
Wieckowska A, McCullough AJ, Feldstein AE. (2007)
Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: Present and future.
Hepatology. 2007 Jul 27;46(2):582‑589
»Abstract
Reply:Wieckowska A, McCullough AJ, Feldstein AE. (2007)
Hepatology. 2007 Nov 28;46(6):2048 [Epub ahead of print]
»Abstract
Yagmur E, Trautwein C, Leers MP, Gressner AM, Tacke F. (2007)
Elevated apoptosis‑associated cytokeratin 18 fragments (CK18Asp386) in serum of patients with chronic liver diseases indicate hepatic and biliary inflammation.
Clin Biochem. 2007 Jan 17;
»Abstract
Yilmaz Y, Dolar E, Ulukaya E, Akgoz S, Keskin M, Kiyici M, Aker S, Yilmaztepe A, Gurel S, Gulten M, Nak SG. (2007)
Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis.
World J Gastroenterol. 2007 Feb 14;13(6):837‑44.
»Abstract
2006
Volkmann X, Cornberg M, Wedemeyer H, Lehner F, Manns MP, Schulze‑Osthoff K, Bantel H. (2006)
Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infection.
Hepatology. 2006 Jun;43(6):1311‑6.
»Abstract
Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE. (2006)
In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease.
Hepatology. 2006 Jul;44(1):27‑33.
»Abstract
2005
Kronenberger B, Wagner M, Herrmann E, Mihm U, Piiper A, Sarrazin C, Zeuzem S. (2005)
Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.
J Viral Hepat. 2005 May;12(3):307‑14.
»Abstract
Seidel N, Volkmann X, Langer F, Flemming P, Manns MP, Schulze‑Osthoff K, Bantel H. (2005)
The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum.
Hepatology. 2005 Jul;42(1):113‑20.
»Abstract
2004
Bantel H, Lugering A, Heidemann J, Volkmann X, Poremba C, Strassburg CP, Manns MP, Schulze‑Osthoff K. (2004)
Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury.
Hepatology. 2004 Nov;40(5):1078‑87.
»Abstract
Ramskogler K, Brunner M, Hertling I, Dvorak A, Kapusta N, Krenn C, Moser B, Roth G, Lesch OM, Ankersmit HJ, Walter H. (2004)
CDT values are not influenced by epithelial cell apoptosis in chronic alcoholic patients‑preliminary results.
Alcohol Clin Exp Res. 2004 Sep;28(9):1396‑8.
»Abstract
